Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H8FNO4 |
| Molecular Weight | 164.1223 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC([18F])C(O)=O)C(O)=O
InChI
InChIKey=JPSHPWJJSVEEAX-OWPBQMJCSA-N
InChI=1S/C5H8FNO4/c6-2(4(8)9)1-3(7)5(10)11/h2-3H,1,7H2,(H,8,9)(H,10,11)/t2?,3-/m0/s1/i6-1
| Molecular Formula | C5H8FNO4 |
| Molecular Weight | 164.1223 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:31:35 GMT 2023
by
admin
on
Sat Dec 16 11:31:35 GMT 2023
|
| Record UNII |
FB9L37AF2L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
24786230
Created by
admin on Sat Dec 16 11:31:35 GMT 2023 , Edited by admin on Sat Dec 16 11:31:35 GMT 2023
|
PRIMARY | |||
|
FB9L37AF2L
Created by
admin on Sat Dec 16 11:31:35 GMT 2023 , Edited by admin on Sat Dec 16 11:31:35 GMT 2023
|
PRIMARY | |||
|
C157280
Created by
admin on Sat Dec 16 11:31:35 GMT 2023 , Edited by admin on Sat Dec 16 11:31:35 GMT 2023
|
PRIMARY | |||
|
1022082-18-3
Created by
admin on Sat Dec 16 11:31:35 GMT 2023 , Edited by admin on Sat Dec 16 11:31:35 GMT 2023
|
PRIMARY | |||
|
300000042444
Created by
admin on Sat Dec 16 11:31:35 GMT 2023 , Edited by admin on Sat Dec 16 11:31:35 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
RESULTS: Uptake of the tracer was highest in the kidneys due to renal excretion of the tracer, followed by the pancreas, heart wall and osteogenic cells. The mean organ doses were: kidneys 38.4 +/- 11.2 .MU.Sv/MBq, pancreas 23.2 +/- 3.8 .MU.Sv/MBq, heart wall 17.4 +/- 4.1 .MU.Sv/MBq, and osteogenic cells 13.6 +/- 3.5 .MU.Sv/MBq. The calculated ED was 8.9 +/- 1.5 .MU.Sv/MBq. CONCLUSION: Based on the distribution and dose estimates, the calculated radiation dose of BAY 85-8050 is 2.67 +/- 0.45 mSv at a patient dose of 300 MBq, which compares favourably with the radiation dose of FDG (5.7 mSv).
|
